JP2015510508A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015510508A5 JP2015510508A5 JP2014555762A JP2014555762A JP2015510508A5 JP 2015510508 A5 JP2015510508 A5 JP 2015510508A5 JP 2014555762 A JP2014555762 A JP 2014555762A JP 2014555762 A JP2014555762 A JP 2014555762A JP 2015510508 A5 JP2015510508 A5 JP 2015510508A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- hydrogen
- heteroaryl
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- -1 methylenedioxyphenyl Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 0 *C1OC1C(N(*)*)=O Chemical compound *C1OC1C(N(*)*)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261593664P | 2012-02-01 | 2012-02-01 | |
| US61/593,664 | 2012-02-01 | ||
| PCT/US2013/024364 WO2013116663A1 (en) | 2012-02-01 | 2013-02-01 | Novel cysteine protease inhibitors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015510508A JP2015510508A (ja) | 2015-04-09 |
| JP2015510508A5 true JP2015510508A5 (enExample) | 2016-03-24 |
| JP6175078B2 JP6175078B2 (ja) | 2017-08-02 |
Family
ID=48905878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014555762A Expired - Fee Related JP6175078B2 (ja) | 2012-02-01 | 2013-02-01 | 新規のシステインプロテアーゼ阻害剤及びその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US9403843B2 (enExample) |
| EP (1) | EP2811999B1 (enExample) |
| JP (1) | JP6175078B2 (enExample) |
| WO (1) | WO2013116663A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6175078B2 (ja) * | 2012-02-01 | 2017-08-02 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | 新規のシステインプロテアーゼ阻害剤及びその使用 |
| JP6768270B2 (ja) * | 2015-08-03 | 2020-10-14 | 学校法人神戸学院 | ビオチン直接結合型タンパク質活性調節物質 |
| US12282014B2 (en) | 2015-11-19 | 2025-04-22 | Dana-Farber Cancer Institute, Inc. | Methods of identifying compounds that interfere with ERG-driven misguidance of BAF complexes in TMPRSS2-ERG driven prostate cancers |
| EP3746124A4 (en) | 2018-01-30 | 2021-10-27 | Foghorn Therapeutics Inc. | COMPOUNDS AND THEIR USES |
| WO2020081588A1 (en) | 2018-10-17 | 2020-04-23 | Dana-Farber Cancer Institute, Inc. | Swi/snf family chromatin remodeling complexes and uses thereof |
| US12384776B2 (en) | 2019-01-29 | 2025-08-12 | Foghorn Therapeutics Inc. | Compounds and uses thereof |
| JP7561195B2 (ja) | 2020-01-29 | 2024-10-03 | フォグホーン セラピューティクス インコーポレイテッド | 化合物及びその使用 |
| US12383555B2 (en) | 2020-05-20 | 2025-08-12 | Foghorn Therapeutics Inc. | Methods of treating cancers |
| CN112321686B (zh) * | 2020-11-16 | 2022-07-05 | 北京大学深圳研究生院 | 一种靶向新冠肺炎病毒刺突蛋白的稳定多肽及其用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5942672B2 (ja) * | 1975-08-11 | 1984-10-16 | 大正製薬株式会社 | ロイシルアグマチン化合物の製造法 |
| JPS5547668A (en) * | 1978-09-30 | 1980-04-04 | Taisho Pharmaceut Co Ltd | Epoxysuccinamic acid |
| JPS55115878A (en) * | 1979-02-27 | 1980-09-06 | Taisho Pharmaceut Co Ltd | Epoxysuccinic acid derivative |
| JPH08104683A (ja) * | 1993-10-29 | 1996-04-23 | Takeda Chem Ind Ltd | エポキシコハク酸誘導体 |
| WO1995032954A1 (en) | 1994-05-31 | 1995-12-07 | Takeda Chemical Industries, Ltd. | Epoxysuccinic acid derivatives, their production and use |
| JPH08119983A (ja) * | 1994-07-08 | 1996-05-14 | Fujisawa Pharmaceut Co Ltd | 新規化合物ｗｆ１４８６５、その製造方法およびその用途 |
| CA2258354A1 (en) | 1997-04-18 | 1998-10-29 | Taiho Pharmaceutical Co., Ltd. | Novel epoxysuccinamide derivatives or salts thereof |
| AUPS192602A0 (en) * | 2002-04-23 | 2002-05-30 | Resmed Limited | Nasal mask |
| BRPI0712868A2 (pt) | 2006-06-13 | 2013-05-07 | Univ Leland Stanford Junior | inibidores epàxidos de cisteÍna proteases |
| WO2010074783A1 (en) | 2008-12-23 | 2010-07-01 | The Trustees Of Columbia University In The City Of New York | Phosphodiesterase inhibitors and uses thereof |
| US20110105603A1 (en) * | 2010-08-06 | 2011-05-05 | American Life Science Pharmaceuticals, Inc. | Compositions and methods for treating beta-amyloid related diseases |
| ES2907862T3 (es) | 2009-12-10 | 2022-04-26 | Univ Columbia | Activadores de histona acetiltransferasa y usos de los mismos |
| EP3323813B1 (en) | 2010-12-22 | 2020-08-26 | The Trustees of Columbia University in the City of New York | Histone acetyltransferase modulators and uses thereof |
| JP6175078B2 (ja) * | 2012-02-01 | 2017-08-02 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | 新規のシステインプロテアーゼ阻害剤及びその使用 |
-
2013
- 2013-02-01 JP JP2014555762A patent/JP6175078B2/ja not_active Expired - Fee Related
- 2013-02-01 WO PCT/US2013/024364 patent/WO2013116663A1/en not_active Ceased
- 2013-02-01 EP EP13743556.6A patent/EP2811999B1/en active Active
- 2013-02-01 US US14/376,361 patent/US9403843B2/en active Active
-
2016
- 2016-06-24 US US15/192,113 patent/US10647709B2/en active Active